Replicating adenovirus vectors

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S093100, C424S093600, C435S320100, C435S325000, C435S069100, C435S455000, C435S456000, C435S457000, C435S235100, C536S023100, C536S023720, C536S023200, C536S024100

Reexamination Certificate

active

06946126

ABSTRACT:
The present invention provides replicating [100K−] adenovirus vectors that have an impairment in 100K activity. In particular preferred embodiments, the impairment is the result of a deletion in the 100K coding region of the adenovirus vector genome. It is further preferred that the adenovirus produces the E1 gene products. In an alternate embodiment, the adenovirus produces the E1a gene products, but has an impairment in the E1b coding region, such that replication of the virus is limited to p53− cells. Also described are methods of making and administering the inventive adenovirus vectors to a cell or to a subject. Further provided is use of the inventive [100K−] Ad vectors as a helper virus for the production of vector stocks of adeno-associated virus.

REFERENCES:
patent: 6328958 (2001-12-01), Amalfitano et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Replicating adenovirus vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Replicating adenovirus vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Replicating adenovirus vectors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3442742

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.